Potential risks include hormone imbalances, effects on blood sugar levels, and increased IGF-1 (insulin-like growth factor) levels, which may lead to other risks over time
Key Takeaways Retatrutide is a once-weekly injectable triple agonist targeting GLP-1, GIP, and glucagon receptors Starting dose is typically 1 mg weekly, titrating up gradually to minimize side effects Maintenance doses range from 8 mg to 12 mg weekly based on individual response Titration is critical for balancing weight loss efficacy with tolerability Clinical trials show significant weight reduction compared to placebo Always work with a healthcare provider to determine your optimal dosing schedule Overview of Retatrutide What is Retatrutide
doi: 10.1111/DOM.12824 50 LiuLShiHShiYWangAGuoNTaoHet al
Following a steady injection schedule plays a key role in achieving the best results
Login/Sign Up Login/Sign Up 1040 with coupons & bank offers*
Common locations include the upper arm, abdomen, back, or thigh